Post-COVID-19 condition patients' utilisation of healthcare resources after implementation of an integrated care unit

The economic effects of post-COVID-19 condition (PCC) remain uncertain despite clearer clinical factors, posing challenges for healthcare professionals. This article investigates the demographic and clinical characteristics of PCC patients and compares their healthcare resource utilization in compar...

Descripción completa

Detalles Bibliográficos
Autores: Vicente-Gómez, José Ángel, de Muniategui Climente, Martín, Loste, Cora, Barreales, Saúl, Ríos, Laura Ricou, Paredes, Roger|||0000-0002-6553-691X, Mateu, Lourdes|||0000-0001-7223-7611, Segui, Francesc Lopez
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:dnet:uabarcelona_::03de55fd676ba0d32db2dfeea0357a7a
Acceso en línea:https://ddd.uab.cat/record/327820
https://dx.doi.org/urn:doi:10.1186/s12962-025-00667-z
Access Level:acceso abierto
Palabra clave:COVID-19
Economic evaluation
Healthcare utilisation
Post-COVID-19 condition
Long COVID
Descripción
Sumario:The economic effects of post-COVID-19 condition (PCC) remain uncertain despite clearer clinical factors, posing challenges for healthcare professionals. This article investigates the demographic and clinical characteristics of PCC patients and compares their healthcare resource utilization in comparison to a patient cohort representative of the population. A retrospective and cohort-comparative observational study was conducted, comparing PCC population before and after diagnosis with a control group. Demographic and clinical variables were analysed to describe the population. Economic analysis was performed to evaluate the resource costs in procedures and primary, secondary and emergency care. PCC patients (N = 341) were older with higher cardiovascular risk factors compared to controls (N = 49,078). There were differences in the socio-economic distribution between male and female in the PCC patients. Hypertension and diabetes mellitus type 2 were the most common chronic diseases observed among the case patients. PCC patients were four times as costly as control patients, with increased utilisation of healthcare resources. However, post-diagnosis PCC patients showed a reduction in costs, primarily driven by decreased primary care visits and hospitalisations. Coordinated care for PCC patients leads to cost reductions and improved resource utilisation. Further research should investigate long-term health outcomes and establish causal relationships between COVID-19 sequelae and healthcare resource utilisation. The online version contains supplementary material available at 10.1186/s12962-025-00667-z.